A classification tree approach for pituitary adenomas

Human Pathology

Volumn 43, Issue 10, 2012, Pages 1627-1637

  Righi, Alberto ^a,b   Agati, Patrizia ^a   Sisto, Andrea ^c   Frank, Giorgio ^d   Faustini Fustini, Marco ^d   Agati, Raffaele ^d   Mazzatenta, Diego ^d   Farnedi, Anna ^a   Menetti, Federico ^d   Marucci, Gianluca ^a   Foschini, Maria P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d BELLARIA HOSPITAL   (Italy)

Author keywords

Ki 67; p53; Pituitary adenoma; Prognosis

Indexed keywords

CORTICOTROPIN; KI 67 ANTIGEN; PROTEIN P53;

ACTH SECRETING ADENOMA; ADRENOCORTICOTROPIN SILENT TYPE I ADENOMA; ADRENOCORTICOTROPIN SILENT TYPE II ADENOMA; ADRENOCORTICOTROPIN SILENT TYPE III ADENOMA; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CLINICAL FEATURE; FEMALE; GONADOTROPIC CELL ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AREA UNDER CURVE; DISEASE PROGRESSION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866516573     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.12.003     Document Type: Article

References (31)

1. F. Salehi, A. Agur, B.W. Scheithauer, K. Kovacs, R.V. Lloyd, and M. Cusimano Ki-67 in pituitary neoplasms: a review - part I Neurosurgery 65 2009 429 437
2. R.V. Lloyd, K. Kovacs, and W.F. Young Jr Tumors of the pituitary R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, World Health Organization classification of tumors: pathology and genetics: tumors of endocrine organs 2004 Lyon IARC 10 47
3. S. Dubois, S. Guyétant, and P. Menei Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery Eur J Endocrinol 157 2007 141 147 (Pubitemid 47233117)
4. S.J. Hentschel, E. McCutcheon, W. Moore, and F.A. Durity P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas Can J Neurol Sci 30 2003 215 219 (Pubitemid 37064515)
5. C.B. Pizarro, M.C. Oliveira, L.B. Coutinho, and N.P. Ferreira Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody Braz J Med Biol Res 37 2004 235 243 (Pubitemid 38268156)
6. B.W. Scheithauer, T.A. Gaffey, and R.V. Lloyd Pathobiology of pituitary adenomas and carcinomas Neurosurgery 59 2006 341 353 (Pubitemid 44325877)
7. H.E. Turner, Z. Nagy, K.C. Gatter, M.M. Esiri, J.A. Wass, and A.L. Harris Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumor behaviour Br J Cancer 82 2000 1441 1445 (Pubitemid 30175911)
8. M. Filippella, F. Galland, and M. Kujas Pituitary tumor transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study Clin Endocrinol 65 2006 536 543 (Pubitemid 44414280)
9. M.L. Jaffrain-Rea, D. Di Stefano, and G. Minniti A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumors: secreting versus non-secreting adenomas Endocr Relat Cancer 9 2002 103 113 (Pubitemid 34832163)
10. H. Nakabayashi, I. Sunada, and M. Hara Immunohistochemical analyses of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas J Histochem Cytochem 49 2001 1193 1194 (Pubitemid 32800543)
11. K.I. Paek, S.H. Kim, and S.H. Song Clinical significance of Ki-67 labeling index in pituitary macroadenoma J Korean Med Sci 20 2005 489 494
12. R. Gejman, B. Swearingen, and E.T. Hedley-Whyte Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas Hum Pathol 39 2008 758 766 (Pubitemid 351601606)
13. A. Fusco, M.C. Zatelli, and A. Bianchi Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas J Clin Endocrinol Metab 93 2008 2746 2750 (Pubitemid 352008545)
14. B.P. Meij, M.B. Lopes, D.B. Ellegala, T.D. Alden, and E.R. Laws Jr The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery J Neurosurg 96 2002 195 208 (Pubitemid 34230231)
15. T.W. Noh, H.J. Jeong, M.K. Lee, T.S. Kim, S.H. Kim, and E.J. Lee Predicting recurrence of nonfunctioning pituitary adenomas J Clin Endocrinol Metab 94 2009 4406 4413
16. M. Losa, A. Franzin, and F. Mangili Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results Neurosurgery 47 2000 1313 1318
17. Y. Ogawa, H. Ikeda, and T.J. Tominaga Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3% Endocrinol Invest 32 2009 581 584
18. L. Mastronardi, A. Guiducci, C. Spera, F. Puzzilli, F. Liberati, and G. Maira Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody J Clin Pathol 52 1999 107 111 (Pubitemid 29062344)
19. A. Wierinckx, C. Auger, and P. Devauchelle A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors Endocr Relat Cancer 14 2007 887 900 (Pubitemid 350074076)
20. E.L. Wang, Z.R. Qian, and M.M. Rahman Increased expression of HMGA1 correlates with tumor invasiveness and proliferation in human pituitary adenomas Histopathology 56 2010 501 509
21. E. Ferrante, M. Ferraroni, and T. Castrignanò Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors Eur J Endocrinol 155 2006 823 829 (Pubitemid 46040620)
22. L.M. Auer, and G. Clarici The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: surgical results and tumor-recurrence Neurol Res 7 1985 153 160 (Pubitemid 15248910)
23. S.L. Asa Practical pituitary pathology: what does the pathologist need to know? Arch Pathol Lab Med 132 2008 1231 1240
24. R.V. Lloyd Molecular pathology of pituitary adenomas J Neurooncol 54 2001 111 119 (Pubitemid 33089244)
25. A. Scarpa, W. Mantovani, and P. Capelli Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients Mod Pathol 23 2010 824 833
26. E. Knosp, K. Kitz, and A. Perneczky Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67 Neurosurgery 25 1989 927 930 (Pubitemid 20073386)
27. D.W. Hsu, F. Hakim, and B.M. Biller Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence J Neurosurg 78 1993 753 761 (Pubitemid 23121917)
28. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
29. L. Breiman, J.H. Friedman, R.A. Olshen, and C. Stone Classification and regression trees 1984 Wadsworth Belmont (Calif)
30. M. Al-Shraim, and S.L. Asa The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol 111 2006 1 7 (Pubitemid 43013820)
31. B.K. Kleinschmidt-DeMasters Subtyping does matter in pituitary adenomas Acta Neuropathol 111 2006 84 85